Formidable Asset Management’s DexCom DXCM Stock Holding History

Formidable Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-141,436	Closed	-$962K	–	258
2019 Q1	$962K	Buy	+141,436	New	+$4.97M	0.38%	66

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Formidable Asset Management's DXCM Position: Q2 2019 in Review

Formidable Asset Management sold out of DexCom (DXCM) in Q2 2019, closing a stake of 141,436 shares — an estimated $962K sold.

Formidable Asset Management first reported a position in DXCM in Q1 2019 and held it in 1 quarter. The position peaked at $962K in Q1 2019. 418 funds tracked by Wall St. Rank hold DXCM as of Q2 2019.

Formidable Asset Management reported no remaining DexCom position as of Q2 2019 after selling out during the quarter.
Formidable Asset Management sold 141,436 DexCom shares in Q2 2019, an estimated $962K.
Formidable Asset Management first reported a position in DexCom in Q1 2019 and held it in 1 quarter.
Formidable Asset Management's DexCom position peaked at $962K in Q1 2019.
418 funds tracked by Wall St. Rank held DexCom as of Q2 2019.

Based on Formidable Asset Management's 13F filing for Q2 2019, filed 15 Oct 2019.